Herpes Simplex Virus Infections of the Newborn

Seminars in Perinatology

Volumn 31, Issue 1, 2007, Pages 19-25

  Kimberlin, David W ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

acyclovir; antiviral therapy; herpes simplex virus; HSV; neonatal herpes

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CYTARABINE; IDOXURIDINE; VIDARABINE;

CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DRUG DOSE COMPARISON; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; MEDICAL DECISION MAKING; MORBIDITY; MORTALITY; NEWBORN INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; REVIEW; SERODIAGNOSIS; TREATMENT PLANNING; VIRUS CULTURE;

ANTIVIRAL AGENTS; DIAGNOSIS, DIFFERENTIAL; HERPES SIMPLEX; HUMANS; INFANT, NEWBORN; PROGNOSIS;

EID: 33847039981     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2007.01.003     Document Type: Review

References (51)

1. Hass M. Hepatoadrenal necrosis with intranuclear inclusion bodies: report of a case. Am J Pathol 11 (1935) 127
2. Batignani A. Conjunctivite da virus erpetico in neonato. Boll Ocul 13 (1934) 1217
3. Nahmias A.J., Alford C.A., and Korones S.B. Infection of the newborn with herpesvirus hominis. Adv Pediatr 17 (1970) 185-226
4. Nahmias A.J., Josey W.E., and Naib Z.M. Neonatal herpes simplex infection. Role of genital infection in mother as the source of virus in the newborn. JAMA 199 (1967) 164-168
5. Nahmias A.J., Josey W.E., Naib Z.M., et al. Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol 110 (1971) 825-837
6. Boston Interhospital Virus Study Group. An NIAID-sponsored cooperative antiviral clinical study: failure of high dose 5-iodo-2′-deoxyuridine in the therapy of herpes simplex virus encephalitis. Evidence of unacceptable toxicity. N Engl J Med 292 (1975) 599-603
7. Stevens D.A., Jordan G.W., Waddell T.F., et al. Adverse effect of cytosine arabinoside on disseminated zoster in a controlled trial. N Engl J Med 289 (1973) 873-878
8. Whitley R.J., Nahmias A.J., Soong S.J., et al. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics 66 (1980) 495-501
9. Whitley R.J., Yeager A., Kartus P., et al. Neonatal herpes simplex virus infection: follow-up evaluation of vidarabine therapy. Pediatrics 72 (1983) 778-785
10. Whitley R., Arvin A., Prober C., et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. N Engl J Med 324 (1991) 444-449
11. Kimberlin D.W., Lin C.Y., Jacobs R.F., et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 108 (2001) 230-238
12. Kimberlin D.W., Lakeman F.D., Arvin A.M., et al. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. J Infect Dis 174 (1996) 1162-1167
13. Malm G., and Forsgren M. Neonatal herpes simplex virus infections: HSV DNA in cerebrospinal fluid and serum. Arch Dis Child Fetal Neonatal Ed 81 (1999) F24-F29
14. Brown Z.A., Wald A., Morrow R.A., et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 289 (2003) 203-209
15. Fleming D.T., McQuillan G.M., Johnson R.E., et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 337 (1997) 1105-1111
16. Xu F., McQuillan G.M., Kottiri B.J., et al. Trends in Herpes Simplex Virus Type 2 Infection in the United States, 42nd Annual Meeting of the Infectious Diseases Society of America (2004) Boston, MA, Abstract 739
17. Lafferty W.E., Downey L., Celum C., et al. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 181 (2000) 1454-1457
18. Kimberlin D.W., and Rouse D.J. Genital herpes. N Engl J Med 350 (2004) 1970-1977
19. Kimberlin D.W. Neonatal HSV infections: the global picture. HERPES 11 (2004) 31-32
20. Kimberlin D.W., Lin C.Y., Jacobs R.F., et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 108 (2001) 223-229
21. Whitley R., Arvin A., Prober C., et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N Engl J Med 324 (1991) 450-454
22. Whitley R.J., Corey L., Arvin A., et al. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis 158 (1988) 109-116
23. Whitley R.J. Herpes simplex virus infections. In: Remington J.S., and Klein J.O. (Eds). Infectious Diseases of the Fetus and Newborn Infants. (ed 3) (1990), W.B. Saunders Company, Philadelphia, PA 282-305
24. Sullivan-Bolyai J.Z., Hull H.F., Wilson C., et al. Presentation of neonatal herpes simplex virus infections: implications for a change in therapeutic strategy. Pediatr Infect Dis 5 (1986) 309-314
25. Arvin A.M., Yeager A.S., Bruhn F.W., et al. Neonatal herpes simplex infection in the absence of mucocutaneous lesions. J Pediatr 100 (1982) 715-721
26. American Academy of Pediatrics. Herpes simplex. In: Pickering L.K. (Ed). 2006 Red Book: Report of the Committee on Infectious Diseases. (ed 26) (2006), American Academy of Pediatrics, Elk Grove Village, IL 361-371
27. Rowley A.H., Whitley R.J., Lakeman F.D., et al. Rapid detection of herpes-simplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. Lancet 335 (1990) 440-441
28. Troendle-Atkins J., Demmler G.J., and Buffone G.J. Rapid diagnosis of herpes simplex virus encephalitis by using the polymerase chain reaction. J Pediatr 123 (1993) 376-380
29. Anderson N.E., Powell K.F., and Croxson M.C. A polymerase chain reaction assay of cerebrospinal fluid in patients with suspected herpes simplex encephalitis. J Neurol Neurosurg Psychiatry 56 (1993) 520-525
30. Schlesinger Y., and Storch G.A. Herpes simplex meningitis in infancy. Pediatr Infect Dis J 13 (1994) 141-144
31. Kimura H., Futamura M., Kito H., et al. Detection of viral DNA in neonatal herpes simplex virus infections: frequent and prolonged presence in serum and cerebrospinal fluid. J Infect Dis 164 (1991) 289-293
32. Barbi M., Binda S., Primache V., et al. Use of Guthrie cards for the early diagnosis of neonatal herpes simplex virus disease. Pediatr Infect Dis J 17 (1998) 251-252
33. Diamond C., Mohan K., Hobson A., et al. Viremia in neonatal herpes simplex virus infections. Pediatr Infect Dis J 18 (1999) 487-489
34. Lewensohn-Fuchs I., Osterwall P., Forsgren M., et al. Detection of herpes simplex virus DNA in dried blood spots making a retrospective diagnosis possible. J Clin Virol 26 (2003) 39-48
35. Kimura H., Ito Y., Futamura M., et al. Quantitation of viral load in neonatal herpes simplex virus infection and comparison between type 1 and type 2. J Med Virol 67 (2002) 349-353
36. Atkins J.T. HSV PCR for CNS infections: pearls and pitfalls. Pediatr Infect Dis J 18 (1999) 823-824
37. Kimberlin D., Cloud G., Lakeman F., et al. Serum polymerase chain reaction (PCR) may not diagnose neonatal herpes simplex virus (HSV) disease, 42nd Annual Meeting of the Infectious Diseases Society of America (2004) Boston, MA, Abstract 992
38. Englund J.A., Fletcher C.V., and Balfour Jr. H.H. Acyclovir therapy in neonates. J Pediatr 119 (1991) 129-135
39. Kimberlin D., Powell D., Gruber W., et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J 15 (1996) 247-254
40. Gutierrez K., and Arvin A.M. Long term antiviral suppression after treatment for neonatal herpes infection. Pediatr Infect Dis J 22 (2003) 371-372
41. Fonseca-Aten M., Messina A.F., Jafri H.S., et al. Herpes simplex virus encephalitis during suppressive therapy with acyclovir in a premature infant. Pediatrics 115 (2005) 804-809
42. ACOG practice bulletin. Management of herpes in pregnancy. Number 8 October 1999. Clinical management guidelines for obstetrician-gynecologists. Anonymous. Int J Gynaecol Obstet 68 (2000) 165-173
43. Peng J., Krause P.J., and Kresch M. Neonatal herpes simplex virus infection after cesarean section with intact amniotic membranes. J Perinatol 16 (1996) 397-399
44. Braig S., Luton D., Sibony O., et al. Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral shedding. Eur J Obstet Gynecol Reprod Biol 96 (2001) 55-58
45. Scott L.L., Sanchez P.J., Jackson G.L., et al. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes. Obstet Gynecol 87 (1996) 69-73
46. Scott L.L., Hollier L.M., McIntire D., et al. Acyclovir suppression to prevent recurrent genital herpes at delivery. Infect Dis Obstet Gynecol 10 (2002) 71-77
47. Sheffield J.S., Hill J.B., Hollier L.M., et al. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial. Obstet Gynecol 108 (2006) 141-147
48. Brocklehurst P., Kinghorn G., Carney O., et al. A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection. Br J Obstet Gynaecol 105 (1998) 275-280
49. Andrews W.W., Kimberlin D.F., Whitley R., et al. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. Am J Obstet Gynecol 194 (2006) 774-781
50. Haddad J., Langer B., Astruc D., et al. Oral acyclovir and recurrent genital herpes during late pregnancy. Obstet Gynecol 82 (1993) 102-104
51. Kimberlin D.W. Vertical transmission of HSV (2002) 18th International Union Against Sexually Transmitted Diseases (IUSTI) Europe Congress on Sexually Transmitted Diseases. Vienna, Austria; #SAT12, Int J STD AIDS, pp 60; #SAT12